Clinical Trial Update: A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/II study evaluating LBL-007 with toripalimab for advanced cancers has completed Phase 1/2 testing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• LBL-007
• Toripalimab (Toripalimab)

Snippet

Sponsor: Nanjing Leads Biolabs Co.,Ltd | Conditions: Advanced Malignant Tumors | Phase 1, Phase 2 | Status: COMPLETED